Fisher Asset Management LLC Reduces Position in M.D.C. Holdings, Inc. (NYSE:MDC)

Fisher Asset Management LLC lowered its position in shares of M.D.C. Holdings, Inc. (NYSE:MDCFree Report) by 10.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 130,265 shares of the construction company’s stock after selling 15,014 shares during the quarter. Fisher Asset Management LLC owned about 0.17% of M.D.C. worth $7,197,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Assenagon Asset Management S.A. purchased a new stake in M.D.C. in the fourth quarter valued at approximately $2,232,000. WealthPLAN Partners LLC purchased a new position in shares of M.D.C. during the fourth quarter worth $992,000. Raymond James & Associates boosted its holdings in M.D.C. by 23.0% in the fourth quarter. Raymond James & Associates now owns 898,855 shares of the construction company’s stock valued at $49,662,000 after purchasing an additional 168,214 shares during the last quarter. Cornercap Investment Counsel Inc. acquired a new position in shares of M.D.C. in the 4th quarter valued at about $1,300,000. Finally, Tudor Investment Corp Et Al boosted its stake in shares of M.D.C. by 0.8% in the third quarter. Tudor Investment Corp Et Al now owns 117,754 shares of the construction company’s stock worth $4,855,000 after buying an additional 977 shares during the last quarter. Hedge funds and other institutional investors own 88.08% of the company’s stock.

M.D.C. Price Performance

M.D.C. stock opened at $62.98 on Tuesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 3.92 and a current ratio of 9.76. The company has a market capitalization of $4.73 billion, a price-to-earnings ratio of 11.93 and a beta of 1.54. The company’s 50 day simple moving average is $62.86 and its 200-day simple moving average is $55.87. M.D.C. Holdings, Inc. has a 1 year low of $36.47 and a 1 year high of $63.00.

Insiders Place Their Bets

In related news, Director David E. Blackford sold 6,200 shares of the business’s stock in a transaction on Monday, March 11th. The stock was sold at an average price of $62.69, for a total value of $388,678.00. Following the sale, the director now owns 13,534 shares in the company, valued at approximately $848,446.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 23.30% of the stock is owned by insiders.

Analyst Ratings Changes

MDC has been the topic of a number of recent analyst reports. Raymond James reiterated a “market perform” rating on shares of M.D.C. in a research report on Wednesday, February 7th. StockNews.com initiated coverage on shares of M.D.C. in a research note on Sunday. They issued a “hold” rating on the stock. Finally, Evercore ISI cut shares of M.D.C. from an “outperform” rating to an “in-line” rating and upped their price objective for the stock from $57.00 to $63.00 in a research report on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $52.13.

View Our Latest Report on MDC

M.D.C. Company Profile

(Free Report)

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Articles

Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDCFree Report).

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.